Page last updated: 2024-09-03

27-hydroxycholesterol and Cancer of Liver

27-hydroxycholesterol has been researched along with Cancer of Liver in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Chen, Z; He, T; Jia, H; Li, Y; Lin, J; Lu, L; Shao, W; Tao, B; Yi, C; Zhang, C; Zhang, P; Zhu, W1
Cai, R; Dai, Y; Jiao, Y; Jin, M; Li, L; Li, Y; Tang, L; Wu, L; Yang, H; Yang, Y; Zhang, Z; Zhou, Y1

Other Studies

2 other study(ies) available for 27-hydroxycholesterol and Cancer of Liver

ArticleYear
27-Hydroxycholesterol promotes metastasis by SULT2A1-dependent alteration in hepatocellular carcinoma.
    Cancer science, 2022, Volume: 113, Issue:8

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Hydroxycholesterols; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Prognosis

2022
27-Hydroxycholesterol is a specific factor in the neoplastic microenvironment of HCC that causes MDR via GRP75 regulation of the redox balance and metabolic reprogramming.
    Cell biology and toxicology, 2022, Volume: 38, Issue:2

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Multiple; Gene Expression Regulation, Neoplastic; HSP70 Heat-Shock Proteins; Humans; Hydroxycholesterols; Liver Neoplasms; Membrane Proteins; Mice; Mice, Nude; Oxidation-Reduction; Tumor Microenvironment

2022